SLFN11 sensitizes cancer cells to therapeutic drugs by selectively catalyzing the cleavage of Leu-TAA and Leu-AAG tRNAs in response to camptothecin DDA treatment, thereby inhibiting the translation rate of proteins enriched for these codons.
- Manqing Li
- Elaine Kao
- Michael David